JP Patent

JP5657789B2 — 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム

Assigned to Laboratoires Thea SAS · Expires 2015-01-21 · 11y expired

What this patent protects

Patent listed against Xalatan.

Drugs covered by this patent

Xalatan (LATANOPROST) · Thea Pharma

Patent Metadata

Patent number: JP5657789B2
Jurisdiction: JP
Classification: —
Expires: 2015-01-21
Drug substance claim: No
Drug product claim: No
Assignee: Laboratoires Thea SAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.